COGT (Cogent Biosciences) Buyback Yield %: -2.73 (As of Jun. 30, 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $38.70
! 4 Warning Signs
View Full Analysis

What is Cogent Biosciences Buyback Yield %?

Cogent Biosciences COGT -0.12% 25 Buyback Yield % is -2.73 as of Jun. 30, 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 742 Biotechnology companies, Cogent Biosciences ranks better than 66.98% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cogent Biosciences's current buyback yield was -2.73%.

Cogent Biosciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences Buyback Yield % Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.11 -20.04 -31.95 -24.76 -2.79

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.50 -2.96 -11.95 -2.79 -2.75

COGT vs SRRK, CGON, LGND: Buyback Yield % Comparison

For the Biotechnology subindustry, Cogent Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogent Biosciences Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cogent Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cogent Biosciences's Buyback Yield % falls into.


COGT
25GF Score
Cogent Biosciences Inc COGT
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cogent Biosciences's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 159.323) / 5718.0096
=-2.79%

Cogent Biosciences's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 180.785) / 6573.09126
=-2.75%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.73 mean?
Cogent Biosciences (COGT) has a Buyback Yield % of -2.73 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cogent Biosciences and its competitors. According to the industry distribution chart, Cogent Biosciences ranks #245 out of 742 companies in the Biotechnology industry, placing it in the top 33%.
Is Cogent Biosciences' Buyback Yield % too high?
Cogent Biosciences' current Buyback Yield % is -2.73. Based on the distribution chart, Cogent Biosciences ranks #245 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Buyback Yield % compare to SRRK and CGON?
According to the Biotechnology industry distribution chart, Cogent Biosciences ranks #245 out of 742 companies for Buyback Yield %. This puts Cogent Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current Buyback Yield % is -2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Buyback Yield % of -2.73. The current Buyback Yield % is -2.73. Cogent Biosciences' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Buyback Yield % is -2.73 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.70
Price